# Contact Auroa Peptides — Editorial Desk

> Reach the Auroa Peptides editorial desk regarding citations, corrections, or research-related correspondence about our Skin & Aesthetics peptide digest.

Correspondence on citations, corrections, and research-related notes — the things a reference desk most wants to hear about.

## Editorial correspondence

Auroa Peptides welcomes correspondence about the research record: a citation quoted inaccurately, a regulatory reference that has since changed, or a peer-reviewed study on GHK-Cu, BPC-157, TB-500 or the GLOW combination that merits inclusion in the [references list](/references). Corrections that sharpen the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable notes are specific: they name the page, the exact passage in question, and a supporting DOI or PubMed ID. That lets us verify a proposed change against the source directly.

**Editorial mailbox:** editors@auroapeptides.com

## What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things are outside what this site can address. Auroa Peptides is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any compound discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or evaluate whether a research finding applies to a particular person.
- Sell, source, recommend, or help locate any compound from any supplier or clinic.
- Answer requests from athletes subject to anti-doping rules about the GLOW blend or its constituents, given that two of its three peptides are prohibited by WADA.

Readers seeking medical or cosmetic guidance should consult a licensed clinician in their own jurisdiction. Editorial correspondence is monitored intermittently; responses are not guaranteed.

---

A measured digest of peer-reviewed skin and aesthetics peptide research — citations in hand, no products on offer.